Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Rigel Pharmaceuticals Inc
About RIGL
Rigel Pharmaceuticals, Inc. is a biotechnology company. The Company is engaged in developing and providing therapies for patients with hematologic disorders and cancer. It focuses on products that address signaling pathways that are critical to disease mechanisms. Its products include TAVALISSE, REZLIDHIA, and GAVRETO. TAVALISSE is an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. REZLIDHIA is used for the treatment of adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation. GAVRETO is a once daily, small molecule, oral, kinase inhibitor of wild type rearranged during transfection (RET) and oncogenic RET fusions. It is used for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory.
Market Capitalisation
$543.41M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
667.32K
High today
$33.01
Low today
$29.66
Open price
$30.22
52-week high
$52.24
52-week low
$17.65
Ready to start your investing journey with Stake?
Open an accountHow do I buy RIGL shares in Australia?
Buying RIGL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Rigel Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RIGL
What is the ticker symbol of Rigel Pharmaceuticals Inc?
The ticker symbol for Rigel Pharmaceuticals Inc is RIGL.
How much is one share of RIGL?
One share of RIGL is valued at $32.40 as of 13 May 2026.
What is the market capitalisation of Rigel Pharmaceuticals Inc RIGL?
As of 13 May 2026 Rigel Pharmaceuticals Inc has a market cap of $543.41M.
What is the P/E ratio of RIGL?
The Price to Earnings ratio of RIGL is 1.59.
What is the Earnings Per Share of RIGL?
The Earnings Per Share of RIGL is $18.43.
What is the 52-week high for Rigel Pharmaceuticals Inc stock?
The Rigel Pharmaceuticals Inc 52-week high stock price is $52.24.
What is the 52-week low for Rigel Pharmaceuticals Inc stock?
The Rigel Pharmaceuticals Inc 52-week low stock price is $17.65.
Can I buy RIGL shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy RIGL shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RIGL on Stake
- Buy RIGL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RIGL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RIGL related stocks